Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment

Figure 1

Serum levels of MLKL in critically ill patients at admission to the intensive care unit. (a) Serum concentrations of MLKL were analyzed by ELISA in critically ill patients at admission to the ICU and healthy blood donors as controls. (b) MLKL levels were analyzed with respect to the disease severity according to the APACHE-II score. (c) MLKL levels were analyzed with respect to the presence of type 2 diabetes. (d) MLKL levels were analyzed with respect to the presence of obesity (BMI > 30 kg/m²). (e) MLKL serum levels were analyzed in patients with sepsis and patients that did not fulfill the sepsis criteria. Asterisks and open circles indicate outlier values.

(a)

(b)

(c)

(d)

(e)